Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib

Wenn, K.; Lange, T.; Brümmendorf, Tim Henrik; Ziegler, Patrick; Koschmieder, Steffen; Hochhaus, A.; Wilop, S.; Giles, F. J.; Hasenbank, C.; Frank, O.; Tomala, L.; Vankann, L.; Beier, F.; Müller, M. C.

doi:1476-5551

TY  - JOUR
AU  - Wenn, K.
AU  - Tomala, L.
AU  - Wilop, S.
AU  - Vankann, L.
AU  - Hasenbank, C.
AU  - Frank, O.
AU  - Hochhaus, A.
AU  - Giles, F. J.
AU  - Lange, T.
AU  - Müller, M. C.
AU  - Koschmieder, Steffen
AU  - Beier, F.
AU  - Ziegler, Patrick
AU  - Brümmendorf, Tim Henrik
TI  - Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib
JO  - Leukemia : normal and malignant hemopoiesis
VL  - 29
IS  - 12
SN  - 0887-6924
CY  - Basingstoke
PB  - Nature Publishing Group
M1  - RWTH-CONV-092106
SP  - 2402-2404
PY  - 2015
LB  - PUB:(DE-HGF)16
UR  - <Go to ISI:>//WOS:000366393900016
C6  - pmid:26369986
DO  - DOI:10.1038/leu.2015.245
UR  - https://publications.rwth-aachen.de/record/567734
ER  -

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines